Skip to main content
OpenTrials
Completed

NCT Number: NCT01522781

10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis

The purpose of this study is to obtain a prospective database which will allow analysis of total knee outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Fife Health Board

Kirkcaldy, Fife, KY2 5AH, United Kingdom

About this study

A prospective database was set up in October 1998. Patient details are collected pre-operatively, intra-operatively and immediately post operatively. Patients are then followed up in a dedicated knee clinic at 6 months, 18 months, 3 years and 5 years. Data such as SF12 and the American knee society score has been done at each visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients undergoing total knee replacement in Fife

Treatment and study plan

Primary outcomes

  1. Clinical outcome of the Sigma knee at 10 years

    Time frame: 10 years

    Patient satisfaction scores SF 12 and Oxford American Knee society score

Secondary outcomes

  1. Radiographic outcomes at 10 years

    Time frame: 10 years

    looking for failure by identitying lucent lines and osteolysis

Sponsors and collaborators

Lead sponsor

NHS Fife

Other Gov

Collaborators

  • DePuy International

Registry information

Important dates

Study start
1998
Primary completion
2008
Study completion
2008
First posted
Feb 1, 2012
Registry last updated
Feb 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.